InVitro International Past Earnings Performance
Past criteria checks 0/6
InVitro International's earnings have been declining at an average annual rate of -21.8%, while the Medical Equipment industry saw earnings growing at 11.3% annually. Revenues have been declining at an average rate of 2.9% per year. InVitro International's return on equity is 0.1%, and it has net margins of 0.2%.
Key information
-21.8%
Earnings growth rate
-22.5%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | -2.9% |
Return on equity | 0.1% |
Net Margin | 0.2% |
Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
No updates
Recent updates
No updates
Revenue & Expenses BreakdownBeta
How InVitro International makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 23 | 1 | 0 | 1 | 0 |
30 Sep 22 | 1 | 0 | 1 | 0 |
30 Sep 21 | 1 | 0 | 1 | 0 |
30 Sep 20 | 1 | 0 | 1 | 0 |
30 Sep 19 | 1 | 0 | 1 | 0 |
30 Sep 18 | 1 | 0 | 1 | 0 |
30 Sep 17 | 1 | 0 | 1 | 0 |
30 Sep 16 | 1 | 0 | 1 | 0 |
30 Sep 15 | 1 | 0 | 1 | 0 |
30 Sep 14 | 1 | 0 | 1 | 0 |
Quality Earnings: IVRO has a high level of non-cash earnings.
Growing Profit Margin: IVRO's current net profit margins (0.2%) are lower than last year (2.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IVRO's earnings have declined by 21.8% per year over the past 5 years.
Accelerating Growth: IVRO's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: IVRO had negative earnings growth (-92.7%) over the past year, making it difficult to compare to the Medical Equipment industry average (3.3%).
Return on Equity
High ROE: IVRO's Return on Equity (0.1%) is considered low.